The print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.

This Annual Report on Form 10-K and Johnson & Johnson’s other publicly available documents contain “forward-looking statements” within the meaning of the safe harbor provisions of the …

In 2023, we delivered strong and sustained performance with 9.0% operational sales growth*, excluding the COVID-19 vaccine. Adjusted net earnings were $25.4 billion*. Adjusted diluted …

4 days ago · 1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones …

For discussion on results of operations and financial condition pertaining to the fiscal years 2020 and 2019 see the Company’s Annual Report on Form 10-K for the fiscal year ended January …

Since January 2024, we invested approximately $50 billion in research and development and other inorganic growth opportunities, including the recently announced planned acquisition of …

Johnson & Johnson does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

View the most recent and previous annual reports of Johnson & Johnson at Annreports.com. Made for students, shareholders and professionals.

Feb 16, 2024 · Johnson & Johnson (JNJ) Annual Reports 2002-2025 NYSE:JNJ (498.5B) ... See all annual reports in the United States